These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6779820)

  • 41. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
    Roth DM; Lefer AM; Smith JB; Nicolaou KC
    Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.
    Laffi G; Cominelli F; La Villa G; Fedi S; Pinzani M; Meacci E; Gentilini P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():366-9. PubMed ID: 2959079
    [No Abstract]   [Full Text] [Related]  

  • 46. Patency of saphenous veins used for aortocoronary bypass grafting: effects of platelet-derived mediators.
    Chiavarelli M; Fabi F; Chiavarelli R; Toscano M; Carpi A; Marino B
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():311-4. PubMed ID: 3159217
    [No Abstract]   [Full Text] [Related]  

  • 47. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
    Whittle BJ; Kauffman GL; Moncada S
    Nature; 1981 Jul; 292(5822):472-4. PubMed ID: 7195986
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence that extracellular calcium ions inhibit thromboxane B2 biosynthesis by human platelets.
    Best LC; Jones PB; Russell RG
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1179-85. PubMed ID: 117802
    [No Abstract]   [Full Text] [Related]  

  • 49. Release of human epidermal growth factor from platelets in accordance with aggregation in vitro.
    Nakamura T; Kasai K; Banba N; Ishikawa M; Shimoda S
    Endocrinol Jpn; 1989 Feb; 36(1):23-8. PubMed ID: 2525086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
    Sato T; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hypotensive action of arachidonic acid, slow acting analphylactic substance (SRS-A) and thromboxane A2 in rats].
    Damas J
    C R Seances Soc Biol Fil; 1978; 172(5):1025-8. PubMed ID: 157190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet thromboxanes and serum-cholesterol.
    Tremoli E; Folco G; Agradi E; Galli C
    Lancet; 1979 Jan; 1(8107):107-8. PubMed ID: 84115
    [No Abstract]   [Full Text] [Related]  

  • 54. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
    Rybicki JP; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzodiazepine analogues inhibit arachidonate-induced aggregation and thromboxane synthesis in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Br J Pharmacol; 1990 Dec; 101(4):920-4. PubMed ID: 1964822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Ca2+ influx into platelets induced by thromboxane A2 analog in patients with ischemic heart disease.
    Kobayashi N; Okumura K; Hashimoto H; Ito T; Satake T
    Clin Cardiol; 1989 Aug; 12(8):456-60. PubMed ID: 2766592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.